Generated through the cleavage of the TREM2’s ectodomain by metalloproteases and/or alternative TREM2 splicing, sTREM2 has been shown to reduce amyloidosis, tau hyperphosphorylation, and cognitive deficits in rodent models [74, 75]. The gene discussed is TREM2; the disease is amyloidosis.